Softwr

AI · head to head

LatchBio vs OpenRouter

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Free plan
No
Full reviewWebsite
OpenRouter logo

OpenRouter

Machine Learning

Unified API gateway routing requests across 500+ models from 80+ providers

From
Free
Free plan
Yes
Full reviewWebsite

The short version

  • Only OpenRouter has a free tier, so it costs nothing to try first.
  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; OpenRouter no free tier; all usage incurs cost
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and OpenRouter actually diverge.

Attributes where LatchBio and OpenRouter differ
AttributeLatchBioOpenRouter
Starting priceOn requestFree
Pricing modelquoteusage-based
Free tierNoYes
PlatformsWebAPI, Web
CategoryAIMachine Learning

Identical on both: user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in OpenRouter

Nothing recorded that LatchBio does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot OpenRouter
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot OpenRouter
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot OpenRouter
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot OpenRouter

OpenRouter

  • Multi-model applications optimising for cost or performancenot LatchBio
  • Provider-agnostic deployments avoiding vendor lock-innot LatchBio
  • Enterprise applications with custom data policies and provider requirementsnot LatchBio
  • Development workflows testing multiple models without code changesnot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

OpenRouter

  • No free tier; all usage incurs cost
  • Pricing varies by model; specific rates not published on main site without account access
  • Adds latency through additional routing layer compared to direct provider APIs
  • Dependent on upstream provider uptime and API compatibility

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

OpenRouter

Free
  • FreeFree
    • 50 requests per day
    • Access to 25+ free models across 4 providers
    • Community support
  • Pay-as-you-go$null/variable
    • 5.5% platform fee on inference costs
    • Access to 500+ models across 80+ providers
    • Email support
  • Enterprise$null/custom
    • Negotiable platform fees
    • 200,000 USD of list price inference per month with no fees, then 5% fee after
    • SSO/SAML support

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose OpenRouter if

  • You want to start without paying.
  • You work on API, Web.
OpenRouter review

Questions people ask

Is LatchBio or OpenRouter better?
Neither clearly leads. LatchBio starts at On request and OpenRouter at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or OpenRouter?
OpenRouter has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for OpenRouter.
Does LatchBio or OpenRouter run on more platforms?
LatchBio runs on Web. OpenRouter runs on API, Web.
Can I use OpenRouter for free?
Yes. OpenRouter has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what OpenRouter is typically brought in for.
What can LatchBio do that OpenRouter cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

OpenRouter: How much does OpenRouter charge?

OpenRouter charges a 5.5% platform fee on top of the actual inference costs from selected models. Customers purchase credits on a pay-as-you-go basis with no subscriptions or minimum spend requirements.

Source
LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

OpenRouter: Is there a free tier?

Yes. OpenRouter offers a free tier with 50 requests per day and access to 25+ free models across 4 providers. The free tier provides community support only.

Source
LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

OpenRouter: What does the Enterprise plan include?

The Enterprise plan includes 200,000 USD of list price inference per month at no cost, with a 5% platform fee applied to usage above that threshold. It also includes SSO/SAML support, contractual SLAs, and dedicated support with a shared Slack channel.

Source
LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

More on LatchBio

More on OpenRouter

Keep looking

Other head to heads